Physician profile
Tricia Chan
NPI 1326131616
$307.20
in general payments reported to CMS, 2019-2025
11 companies · $63.07 in 2025
The $63.07 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $60.05 · 2021: $20.25 · 2022: $20.10 · 2023: $52.54 · 2024: $91.19 · 2025: $63.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $51.85 | 2020-2021 | |
| Glaxosmithkline, LLC. | $45.44 | 2020-2023 | Shingrix, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $39.59 | 2025 | Glassia |
| Renalytix Ai, INC. | $23.99 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Dexcom, INC. | $23.58 | 2024 | Dexcom G6 Transmitter |
| Aimmune Therapeutics, INC. | $23.48 | 2025 | Zenpep |
| Astellas Pharma US INC | $22.20 | 2024 | Veozah |
| Pfizer INC. | $21.64 | 2023 | |
| Optinose US, INC. | $21.42 | 2024 | |
| Merck Sharp & Dohme LLC | $20.10 | 2022 | |
| Amgen INC. | $13.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tricia Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.